Maple Leaf Green World Inc. N.MGW

News

[coventrykid]

ORIGINAL: Maple Leaf Green World Inc. Opens Up A New Revenue Stream by Signing A Cultivation Partnership Agreement with Swissx 2021-05-13 08:30 ET - News Release CALGARY, Alberta, May 13, 2021 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (Maple Leaf or the Company) (NEO: MGW, OTCQB: MGWFF) is pleased to announce that its wholly owned subsidiary, Golden State Green World LLC, has signed a cultivation partnership agreement (the Agreement) with APEX Genetics LLC (APEX); a seed genetics firm currently being acquired by Swissx. Swissx was founded by billionaire Alkivades David in 2015 and is known for its CBD product line (available online at www.swissx.com). As the first brand to go mainstream in the US, Swissx consists of a network of complementary brands and companies supporting the extended cannabis lifestyle. Swissxs acquisition of APEX is advancing research into hemp and cannabis with a significant portion devoted to the incredible potential of CBG. Under this Agreement, APEX will supply their proprietary strain, Swissx Melon, a CBD-rich hemp strain, for Maple Leaf to cultivate using its greenhouse technology in a fully automated and climate controlled environment. Maple Leaf will grow, dry and trim the CBD plants to APEXs specifications as outlined in the Agreement, ensuring compliance with local and federal laws and regulations. After harvesting, APEX is committed to distributing the entire production of flower, biomass and trim with the flower price established at US$225 /lb. Maple Leaf will be compensated 85% of the gross sales and APEX will keep the remaining 15%. We are delighted to select Maple Leafs farm in California to grow our genetic strain. We were pleased with the achievements theyve made on their CBG strain that we knew our strain would be in good hands, said Matt Bentley, CEO of APEX Genetics and Swissx Labs. We are excited to work together to develop the most effective CBD products to bring to market, concluded Bentley. APEX will deliver its first batch of 5,000 Swissx Melon seeds to the cultivation site this week. The Company expects each harvest to yield about 5,000 lbs of CBD-rich hemp with an estimated total sale value of US$1.1M with 85% (or US$956,000) to Maple Leaf for a total yearly revenue of approximately US$3.8M. The number of seeds provided from APEX can be increased in subsequent crops pending the success of each harvest. This is a one year contract and is renewable each year. This Agreement will be another milestone for Maple Leaf this year and a tribute to its greenhouse technology and experienced staff. This opens up another new revenue stream for the Company, in addition to the smokable hemp products in development with Hempacco, said Raymond Lai, President & CEO of Maple Leaf. Maple Leaf continues to develop multi-faceted growth opportunities through new product development and strategic partnerships. In the past few months, the Company has established a joint venture (JV) partnership with Hempacco and a cultivation partnership with Swissx. The JV with Hempacco will continue to focus on the Companys new line of CBG hemp cigarettes, Phoenix Crave, and other functional smokes that will disrupt the trillion dollar tobacco industry. The cultivation partnership with APEX will focus on the Companys cultivation technology and expertise to produce high quality CBD/CBG hemp products. The Company continues to be committed to its high quality CBG hemp production and is excited to be partnered with Hempacco, to disrupt tobacco, and with Swissx, to cultivate their CBD genetic strain Swissx Melon. The Companys CBG production yield will not be affected by this Agreement as it has expanded its cultivation capacity to include an outdoor crop. Billy Bewcyk, V.P. of Business Development for the Company is currently in Las Vegas this week for the Tobacco Plus Expo (TPE21) in booth 10106 with Hempacco. The sold out trade show will provide an excellent opportunity to showcase Phoenix Crave CBG hemp cigarettes to clients and distributors.

[Rickathome]

well.... I guess thats something.

[Grizzlyadams1]

Look at all the shares looking for the exit door I wonder why ??? Such amazing news lately but still zero revenue. Raymond giving up millions of shares at 6.5-7.5 and now trying to sell them for quick cash ??? maybe 

[everywhere]

Another company to be a** fk by ray ray